Cargando…

Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma

BACKGROUND: Cortactin is an important regulator involved in invasion and migration of hepatocellular carcinoma (HCC). The aim of this study was to elucidate the forecasting role of cortactin in resectable HCCs. METHODS: We compared the invasiveness and motility among liver epithelial cell line and H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Gang, Huang, Zi-ming, Kong, Ya-Lin, Wen, Dong-Qing, Li, Yu, Ren, Li, Zhang, Hong-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620941/ https://www.ncbi.nlm.nih.gov/pubmed/23518204 http://dx.doi.org/10.1186/1477-7819-11-74

Ejemplares similares

Cortactin expression predicts poor survival in laryngeal carcinoma
por: Gibcus, J H, et al.
Publicado: (2008)

Prognosis of gastric adenocarcinoma associated with girdin, Akt, and cortactin
por: Zhang, Yue, et al.
Publicado: (2022)

Effects of Cortactin Expression on Prognosis in Patients with Breast Cancer
por: Son, Hwangkyu, et al.
Publicado: (2023)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma
por: Liu, Dian-Gang, et al.
Publicado: (2016)

SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma
por: Song, Guo-Qiang, et al.
Publicado: (2022)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2018)

Hypermethylation of UCHL1 Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN)
por: Zhao, Yin, et al.
Publicado: (2020)

Embryonic Morphogen Nodal Is Associated with Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Chen, Jing, et al.
Publicado: (2014)

CDKN3 expression predicates poor prognosis and regulates adriamycin sensitivity in hepatocellular carcinoma in vitro
por: Dai, Wei, et al.
Publicado: (2020)

Cortactin in Epithelial–Mesenchymal Transition
por: Ji, Rong, et al.
Publicado: (2020)

Cortactin function in invadopodia
por: Jeannot, Pauline, et al.
Publicado: (2017)

Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma
por: Cheng, Ya, et al.
Publicado: (2016)

Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients
por: Liu, Can, et al.
Publicado: (2017)

Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma
por: Li, Bin-Kui, et al.
Publicado: (2014)

High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients
por: Peng, Li, et al.
Publicado: (2017)

NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma
por: Jing, Ji-sheng, et al.
Publicado: (2018)

Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma
por: Xia, Hai-Bing, et al.
Publicado: (2018)

Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2014)

Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis
por: Wang, Qing, et al.
Publicado: (2011)

Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis
por: Sun, Quanquan, et al.
Publicado: (2020)

Mitofusin-2 acts as biomarker for predicting poor prognosis in hepatitis B virus related hepatocellular carcinoma
por: Wang, Xiumei, et al.
Publicado: (2018)

Ornithine transcarbamylase downregulation is associated with poor prognosis in hepatocellular carcinoma
por: He, Lin, et al.
Publicado: (2019)

High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Shi-Hong, et al.
Publicado: (2013)

Decreased DC-SIGNR expression in hepatocellular carcinoma predicts poor patient prognosis
por: Xia, Hai-Bing, et al.
Publicado: (2020)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
por: Zhong, Cheng‐Qian, et al.
Publicado: (2018)

Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
por: ZHANG, ZHEN-HAI, et al.
Publicado: (2014)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Correction: Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2022)

Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma
por: Chen, Wanyong, et al.
Publicado: (2018)

High USP22 expression indicates poor prognosis in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2015)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma
por: Zhang, Kainan, et al.
Publicado: (2022)

Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients
por: Bing, Yuntao, et al.
Publicado: (2018)

Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection
por: Shen, Shun-Li, et al.
Publicado: (2014)

Decreased expression of ApoF associates with poor prognosis in human hepatocellular carcinoma
por: Wang, Ya-Bin, et al.
Publicado: (2019)

Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis
por: Huang, Yan, et al.
Publicado: (2012)

Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma
por: Dumitru, Claudia A., et al.
Publicado: (2013)

Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinoma
por: Li, Chongyi, et al.
Publicado: (2015)

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u04qnbgpj37hos3nc58ej1fg3m